We are
already round the corner to 2018, here are the top 10 most read articles from
2017.
News from ACOG 2017: Changing gloves
before abdominal closure brings down the rate of wound infection by almost 50%
in Cesarean Section
Results of a
randomized controlled trial presented at the ACOG 2017 showed
that changing the outer gloves before closing the abdomen decreases the wound
complication of infection, cellulitis and dehiscence.
Clinical review: Updates on Cesarean
Section
Here is a roundup of the latest research on Cesarean Section.
The American Heart Association
updates BP guidelines in 14 years: now 130 is the new 140
The American Heart Association (AHA) and The
American College of Cardiology (ACC) has changed the definition of
hypertension for the first time in 14 years, moving the number from the old
standard of 140/90 to the newly revised 130/80.
According to
the new definition, 130 to 139 mm Hg systolic and or 80 to 89 mm Hg will be
labelled as stage 1 hypertension.
First US baby born after uterine
transplant delivered in Texas
The first
birth as a result of a uterine transplant in the United States took
place on Friday in Texas at the Baylor University Medical Center in Dallas. The
women had undergone a live donor transplant and have received her uterus from
Taylor Siler, 36, a registered nurse in the Dallas area.
New use of old drug: Sildenafil
Citrate (Viagra) improves amniotic fluid index in oligohydramnios.
Sildenafil
Citrate (Viagra) improves amniotic fluid index in pregnancies complicated by
oligohydramnios according to a new
study published ahead of print on March 6,2017 in Journal of
Obstetrics and Gynecology.
WHO updates its guidance on
Tranexamic Acid for the Treatment of Postpartum Hemorrhage
WHO has
recently updated their guidelines for use of Tranexamic acid
for treatment of Postpartum Hemorrhage: TXA should now be included in the
treatment regimen for PPH along with other drugs, irrespective of the cause of
hemorrhage.
CDC releases ‘long awaited’
guidelines for preventing surgical site infections.
The Center
for Disease Control released its much-awaited update to its 1999 guidelines for
the prevention of surgical site infections (SSIs). The guidelines were
published online May 3, 2017 in JAMA.
Finally, an oral drug found effective
in treatment of Uterine Fibroids following successful phase-3 trial
Relugolix
successfully reduced heavy menstrual blood loss among Japanese women in a
Multicenter, Randomized, Double-Blind, Parallel-Group, Phase 3 Study to
Evaluate the Efficacy and Safety of Oral relugolix 40 mg as compared with
injectable leuprolide in the Treatment of Uterine Fibroids.
Now ‘Switch’ the way you suture:
Reinventing suturing technique with the new device
Mellon Medical, a Dutch
MedTech developer has reinvented suturing by developing a device which
enables the surgeon to suture with only one hand, the other hand remaining free
to use as needed. The product is named Switch®, a single use precision
instrument that allows the surgeon to suture tubular structures or skin with
twice the speed of conventional suturing.
A simple, novel solution to identify
and protect ureter during surgery
AllotropeMedical, a Houston
based medical startup has devised StimSite, a novel, hand-held, single use
device that precisely identifies ureter during surgery; thus, eliminating the
need for ureteral stenting.
